Switch theme
Sign up to access all valuation multiples
Maternus-Kliniken AG operates as a German healthcare company focused on senior housing, care facilities, and rehabilitation clinics.
1996
1.9K+
Last FY Revenue $115M
Last FY EBITDA $5.3M
$213M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Maternus-Kliniken achieved revenue of $115M and an EBITDA of $5.3M.
Maternus-Kliniken expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Maternus-Kliniken valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $115M | XXX | XXX | XXX |
| Gross Profit | XXX | $98.2M | XXX | XXX | XXX |
| Gross Margin | XXX | 85% | XXX | XXX | XXX |
| EBITDA | XXX | $5.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 5% | XXX | XXX | XXX |
| EBIT | XXX | -$10.4M | XXX | XXX | XXX |
| EBIT Margin | XXX | -9% | XXX | XXX | XXX |
| Net Profit | XXX | -$16.0M | XXX | XXX | XXX |
| Net Margin | XXX | -14% | XXX | XXX | XXX |
| Net Debt | XXX | $120M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Maternus-Kliniken's stock price is EUR 2 (or $2).
Maternus-Kliniken has current market cap of EUR 32.7M (or $36.7M), and EV of EUR 190M (or $213M).
See Maternus-Kliniken trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $213M | $36.7M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Maternus-Kliniken has market cap of $36.7M and EV of $213M.
Maternus-Kliniken's trades at 1.9x EV/Revenue multiple, and 40.3x EV/EBITDA.
Equity research analysts estimate Maternus-Kliniken's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Maternus-Kliniken's P/E ratio is not available.
See valuation multiples for Maternus-Kliniken and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $36.7M | XXX | $36.7M | XXX | XXX | XXX |
| EV (current) | $213M | XXX | $213M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 40.3x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -20.5x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -2.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -132.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMaternus-Kliniken's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Maternus-Kliniken's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Maternus-Kliniken's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Maternus-Kliniken and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 95% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Maternus-Kliniken acquired XXX companies to date.
Last acquisition by Maternus-Kliniken was XXXXXXXX, XXXXX XXXXX XXXXXX . Maternus-Kliniken acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Maternus-Kliniken founded? | Maternus-Kliniken was founded in 1996. |
| Where is Maternus-Kliniken headquartered? | Maternus-Kliniken is headquartered in Germany. |
| How many employees does Maternus-Kliniken have? | As of today, Maternus-Kliniken has 1.9K+ employees. |
| Is Maternus-Kliniken publicy listed? | Yes, Maternus-Kliniken is a public company listed on ETR. |
| What is the stock symbol of Maternus-Kliniken? | Maternus-Kliniken trades under MAK ticker. |
| When did Maternus-Kliniken go public? | Maternus-Kliniken went public in 1997. |
| Who are competitors of Maternus-Kliniken? | Similar companies to Maternus-Kliniken include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Maternus-Kliniken? | Maternus-Kliniken's current market cap is $36.7M |
| Is Maternus-Kliniken profitable? | Yes, Maternus-Kliniken is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
